Clinical Trial Update: Low-Dose Pioglitazone in Patients With NASH (AIM 2) [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of low-dose pioglitazone for nonalcoholic steatohepatitis in patients with type 2 diabetes, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Florida | Conditions: Type 2 Diabetes Mellitus (T2DM), Nonalcoholic Steatohepatitis | Phase 2 | Status: RECRUITING